secwatch.observer — SEC 8-K summary
======================================

Issuer:     PepGen Inc. (PEPG)
CIK:        0001835597
Form:       8-K
Filed at:   2023-11-15T23:59:59+00:00
Accession:  0000950170-23-064008
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PepGen appoints Howard Mayer, M.D. to board of directors
--------------------------------------------------------

- Howard Mayer appointed to PepGen board effective Nov 15, 2023; fills newly created vacancy expanding board to seven members.
- Dr. Mayer will receive initial option for 22,686 shares under 2022 Stock Plan; annual cash retainers $35k for board, $5k for compensation committee.
- Dr. Mayer was most recently EVP, Head of R&D at Ipsen Biopharmaceuticals (2019-2023); previously SVP, CMO at Shire Pharmaceuticals.
- He brings experience in rare disease clinical development and regulatory filings; will serve on Compensation Committee.
- No family relationships or arrangements with other persons regarding his appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835597/000095017023064008/0000950170-23-064008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835597/000095017023064008/pepg-20231115.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-064008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer